Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis

Annals of Clinical Biochemistry

Volumn 49, Issue 6, 2012, Pages 554-560

  Woth, Gábor ^a   Tokés Füzesi, Margit ^a   Magyarlaki, Tamás ^a   Kovács, Gábor L ^a   Vermes, István ^a   Mühl, Diana ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CARBAPENEM DERIVATIVE; CD42A ANTIGEN; CEPHALOSPORIN DERIVATIVE; FIBRINOGEN RECEPTOR; FLUCONAZOLE; LIPOCORTIN 5; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FUNGEMIA; FUNGUS IDENTIFICATION; GENERAL CONDITION DETERIORATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE COUNT;

AGED; ANNEXIN A5; BLOOD PLATELETS; CANDIDA ALBICANS; CANDIDIASIS; CELL-DERIVED MICROPARTICLES; CLINICAL LABORATORY TECHNIQUES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PLATELET MEMBRANE GLYCOPROTEIN IIB; PROSPECTIVE STUDIES; SEPSIS;

CANDIDA ALBICANS; FUNGI;

EID: 84872480786     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.011215     Document Type: Article

References (24)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10
2. Blanco J, Muriel-Bombín A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 2008;12:R158
3. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327
5. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78
6. Lepak A, Andes D. Fungal sepsis: optimizing antifungal therapy in the critical care setting. Crit Care Clin 2011;27:123-47
7. Girois SB, Chapuis F, Decullier E, Revol BGP. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J Clin Microbiol Infect Dis 2005;24:119-30
8. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-905
9. Yeaman MR. Platelets in defense against bacterial pathogens. Cell Mol Life Sci 2010;67:525-44
10. Morel O, Jesel L, Freyssinet JM, Toti F. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2011;31:15-26
11. Abrams CS, Ellison N, Budzynski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990;75:128-38
12. Nieuwland R, Sturk A. Why do cells release vesicles? Thromb Res 2010;125(Suppl.):S49-51
13. Zahra S, Anderson JAM, Stirling D, Ludlam CA. Microparticles, malignancy and thrombosis. Br J Haematol 2011;152:688-700
14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74
15. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-30
16. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-52
17. Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009;37:1649-54
18. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63
19. Yang QH, Liu DW, Long Y, Liu HZ, Chai WZ, Wang XT. Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect 2009;58:459-64
20. Peschel A. How do bacteria resist human antimicrobial peptides? Trends Microbiol 2002;10:179-86
21. Dürr M, Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 2002;70:6515-7
22. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000;95:930-5
23. Cockerill FR, Wilson JW, Vetter EA, et al. Optimal testing parameters for blood cultures. Clin Infect Dis 2004;38:1724-30
24. Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998;83:1827-34